229 related articles for article (PubMed ID: 2530067)
1. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
Feng YJ; Zhang XY
Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
[TBL] [Abstract][Full Text] [Related]
2. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Thurzó L
Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
[TBL] [Abstract][Full Text] [Related]
3. The status of receptors in the management of endometrial cancer.
Richardson GS; MacLaughlin DT
Clin Obstet Gynecol; 1986 Sep; 29(3):628-37. PubMed ID: 2944683
[No Abstract] [Full Text] [Related]
4. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
Thurzó L; Sas M; Falkay G
Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
[No Abstract] [Full Text] [Related]
5. Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
Fujimoto J; Fujita H; Hosoda S; Okada H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1836-40. PubMed ID: 2531782
[TBL] [Abstract][Full Text] [Related]
6. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
Okada H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
[TBL] [Abstract][Full Text] [Related]
7. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
[TBL] [Abstract][Full Text] [Related]
9. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
Metzger DA; Lessey BA; Soper JT; McCarty KS; Haney AF
Obstet Gynecol; 1991 Nov; 78(5 Pt 2):946-50. PubMed ID: 1833687
[TBL] [Abstract][Full Text] [Related]
10. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptors and response of endometrial cancer to hormones in vitro.
Grönroos M; Mäenpää J; Kangas L; Erkkola R; Paul R; Grenman S
Ann Chir Gynaecol Suppl; 1987; 202():76-9. PubMed ID: 2959189
[TBL] [Abstract][Full Text] [Related]
12. Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment.
Lindahl B; Alm P; Fernö M; Norgren A
Anticancer Res; 1990; 10(3):725-30. PubMed ID: 2142394
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)].
Ohta M; Takeda A; Ninagawa T; Tomoda Y
Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176
[No Abstract] [Full Text] [Related]
14. [Growth of endometrial cancer and hormone].
Kanoh H; Hosono T; Matsui Y; Okudaira Y
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3696-703. PubMed ID: 2531993
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
Ehrlich CE; Young PC; Cleary RE
Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
[TBL] [Abstract][Full Text] [Related]
16. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
Quinn MA; Cauchi M; Fortune D
Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
[TBL] [Abstract][Full Text] [Related]
17. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study of the treatment of uterine leiomyosarcoma in the mouse with progestogen].
Sato Y; Tanaka K; Arakawa O; Ono M; Hirohashi T; Obata N; Takeuchi S
Gan No Rinsho; 1988 Nov; 34(14):1979-84. PubMed ID: 2974492
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
20. [Current status of drug treatment of endometrial carcinoma].
Schulz KD; Kaiser R
Gynakologe; 1983 Jun; 16(2):114-8. PubMed ID: 6193040
[No Abstract] [Full Text] [Related]
[Next] [New Search]